623 related articles for article (PubMed ID: 18242955)
1. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
Ardesjö B; Hansson CM; Bruder CE; Rorsman F; Betterle C; Dumanski JP; Kämpe O; Ekwall O
J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955
[TBL] [Abstract][Full Text] [Related]
2. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis.
Saarinen S; Olerup O; Broomé U
Am J Gastroenterol; 2000 Nov; 95(11):3195-9. PubMed ID: 11095341
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
[TBL] [Abstract][Full Text] [Related]
5. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
6. Relevance of the inner mitochondrial membrane enzyme F1F0-ATPase as an autoantigen in autoimmune liver disorders.
Preuss B; Berg C; Dengjel J; Stevanovic S; Klein R
Liver Int; 2012 Feb; 32(2):249-57. PubMed ID: 22098431
[TBL] [Abstract][Full Text] [Related]
7. Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset.
Bekris LM; Shephard C; Peterson M; Hoehna J; Van Yserloo B; Rutledge E; Farin F; Kavanagh TJ; Lernmark A
Autoimmunity; 2005 Dec; 38(8):567-75. PubMed ID: 16390810
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation.
Salcedo M; Rodríguez-Mahou M; Rodríguez-Sainz C; Rincón D; Alvarez E; Vicario JL; Catalina MV; Matilla A; Ripoll C; Clemente G; Bañares R
Liver Transpl; 2009 May; 15(5):530-9. PubMed ID: 19399747
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
10. Association of the glutathione S-transferase M1 homozygous null genotype with susceptibility to Sjögren's syndrome in Japanese individuals.
Morinobu A; Kanagawa S; Koshiba M; Sugai S; Kumagai S
Arthritis Rheum; 1999 Dec; 42(12):2612-5. PubMed ID: 10616008
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.
Henckaerts L; Jaspers M; Van Steenbergen W; Vliegen L; Fevery J; Nuytten H; Roskams T; Rutgeerts P; Cassiman JJ; Vermeire S; Cuppens H
J Hepatol; 2009 Jan; 50(1):150-7. PubMed ID: 18992954
[TBL] [Abstract][Full Text] [Related]
12. Frequency and significance of anti-glutathione S-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis.
Kato T; Miyakawa H; Ishibashi M
J Autoimmun; 2004 May; 22(3):211-6. PubMed ID: 15041041
[TBL] [Abstract][Full Text] [Related]
13. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases.
Zachou K; Liaskos C; Rigopoulou E; Gabeta S; Papamichalis P; Gatselis N; Georgiadou S; Dalekos GN
Clin Immunol; 2006 May; 119(2):203-12. PubMed ID: 16500150
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of primary sclerosing cholangitis among first-degree relatives.
Bergquist A; Lindberg G; Saarinen S; Broomé U
J Hepatol; 2005 Feb; 42(2):252-6. PubMed ID: 15664252
[TBL] [Abstract][Full Text] [Related]
15. Immune-mediated diseases in primary sclerosing cholangitis.
Lamberts LE; Janse M; Haagsma EB; van den Berg AP; Weersma RK
Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515
[TBL] [Abstract][Full Text] [Related]
16. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R
J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of GSTT1 and GSTM1 and susceptibility to chronic obstructive pulmonary disease (COPD).
Faramawy MM; Mohammed TO; Hossaini AM; Kashem RA; Abu Rahma RM
J Crit Care; 2009 Sep; 24(3):e7-10. PubMed ID: 19664521
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
[TBL] [Abstract][Full Text] [Related]
19. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases.
Martins EB; Graham AK; Chapman RW; Fleming KA
Hepatology; 1996 May; 23(5):988-93. PubMed ID: 8621180
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlation of antimitochondrial antibodies.
Zuber MA; Recktenwald C
Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
